MCMVX
Price
$24.67
Change
-$0.00 (-0.00%)
Updated
Sep 4 closing price
Net Assets
48.29M
VEVYX
Price
$51.54
Change
-$0.12 (-0.23%)
Updated
Sep 4 closing price
Net Assets
14.87B
Interact to see
Advertisement

MCMVX vs VEVYX

MCMVX vs VEVYX Comparison Chart in %
View a ticker or compare two or three
VS
MCMVX vs. VEVYX commentary
Sep 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCMVX is a Hold and VEVYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEVYX has more cash in the bank: 14.9B vs. MCMVX (48.3M). VEVYX pays higher dividends than MCMVX: VEVYX (1.11) vs MCMVX (0.99). MCMVX was incepted earlier than VEVYX: MCMVX (13 years) vs VEVYX (14 years). MCMVX (1.60) is less costly to investors than VEVYX (0.66). VEVYX is a more actively managed with annual turnover of: 45.00 vs. MCMVX (37.00). MCMVX has a lower initial minimum investment than VEVYX: MCMVX (5000) vs VEVYX (1000000). MCMVX annual gain was more profitable for investors over the last year : 18.87 vs. VEVYX (10.82). MCMVX return over 5 years is better than : 32.01 vs. VEVYX (6.56).
MCMVXVEVYXMCMVX / VEVYX
Total Expense Ratio0.860.66130%
Annual Report Gross Expense Ratio1.600.66242%
Fund Existence13 years14 years-
Gain YTD20.04915.465130%
Front LoadN/AN/A-
Min. Initial Investment500010000001%
Min. Initial Investment IRAN/AN/A-
Net Assets48.3M14.9B0%
Annual Yield % from dividends0.991.1190%
Returns for 1 year18.8710.82174%
Returns for 3 years46.1016.35282%
Returns for 5 years32.016.56488%
Returns for 10 years130.8167.00195%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MECZX60.310.32
+0.53%
AMG GW&K International Small Cap Z
MLPFX11.23N/A
N/A
Invesco SteelPath MLP Select 40 A
PFISX13.49-0.01
-0.07%
Principal International Small Company R6
JAMCX34.56-0.13
-0.37%
JPMorgan Mid Cap Value A
BIVRX18.63-0.31
-1.64%
Invenomic Investor